Yahoo Finance High Insider Ownership Growth Stocks On The German Exchange For June 2024
As the German market shows resilience with a notable 0.90% gain in the DAX index, investors are keenly observing shifts and opportunities within this vibrant economy. In such a climate, exploring growth companies with high insider ownership could offer valuable insights into firms with potentially robust internal confidence and strategic alignment.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 75.4% |
Deutsche Beteiligungs (XTRA:DBAN) | 35.4% | 31.6% |
YOC (XTRA:YOC) | 24.8% | 22.2% |
Exasol (XTRA:EXL) | 25.3% | 105.4% |
NAGA Group (XTRA:N4G) | 14.1% | 58.1% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
elumeo (XTRA:ELB) | 25.8% | 99.1% |
Redcare Pharmacy (XTRA:RDC) | 17.7% | 46.9% |
Your Family Entertainment (DB:RTV) | 17.5% | 116.8% |
Friedrich Vorwerk Group (XTRA:VH2) | 18% | 30.4% |
Let's explore several standout options from the results in the screener.
Hypoport
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hypoport SE is a technology-based financial service provider in Germany, with a market capitalization of approximately €1.997 billion.
Operations: The company generates revenue primarily through its Credit Platform and Insurance Platform, which contributed €155.60 million and €66.29 million respectively.
Insider Ownership: 35.1%
Hypoport SE, a growth-oriented company with high insider ownership in Germany, has demonstrated robust financial performance. In Q1 2024, sales increased to €107.47 million from €93.72 million year-over-year, with net income rising significantly to €3.04 million from €0.503 million. Despite a highly volatile share price recently, earnings are expected to grow by 31.9% per year, outpacing the German market forecast of 18.6%. However, its Return on Equity is projected to remain low at 9.1% in three years.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.38 billion.
Operations: The company generates revenue primarily through its DACH segment, which brought in €1.62 billion, and its International operations, contributing €369.34 million.
Insider Ownership: 17.7%
Redcare Pharmacy NV, while trading 40.7% below its estimated fair value, reported a significant increase in Q1 2024 sales to €560.22 million from €372.05 million in the previous year, with a reduced net loss of €7.81 million down from €10.22 million. Despite shareholder dilution over the past year and a low projected Return on Equity of 12.9%, the company is expected to become profitable within three years with earnings growth forecasted at 46.89% per year, outperforming the German market's average revenue growth rate of 5.2%.
Zalando
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Zalando SE is an online retailer specializing in fashion and lifestyle products, with a market capitalization of approximately €5.79 billion.
Operations: The company's revenue is primarily generated from its online platform, amounting to €10.40 billion.
Insider Ownership: 10.4%
Zalando SE, despite a forecasted low Return on Equity of 12.4% in three years, is positioned for robust earnings growth at 26.6% annually, outpacing the German market's 18.6%. Recent activities include presenting at multiple international conferences and providing a modest sales growth outlook for 2024 between 0% and 5%. The company recently reported a quarterly sales of €2.24 billion but incurred a net loss of €8.9 million, reflecting ongoing challenges despite its growth trajectory.
Click to explore a detailed breakdown of our findings in Zalando's earnings growth report.
The valuation report we've compiled suggests that Zalando's current price could be inflated.
Where To Now?
Explore the 18 names from our Fast Growing German Companies With High Insider Ownership screener here.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Searching for a Fresh Perspective?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include XTRA:HYQ XTRA:RDC and XTRA:ZAL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
